Penn Undergraduate Law Journal
  • Home
  • About
    • Mission
    • Masthead
    • Faculty Advisory Board
    • Partner Journals
    • Sponsors
  • Submissions
  • Full Issues
  • The Roundtable
    • Pre-Law Corner
  • Events
  • Contact
    • Contact
    • Apply
    • FAQs
  • Home
  • About
    • Mission
    • Masthead
    • Faculty Advisory Board
    • Partner Journals
    • Sponsors
  • Submissions
  • Full Issues
  • The Roundtable
    • Pre-Law Corner
  • Events
  • Contact
    • Contact
    • Apply
    • FAQs

The Roundtable


Welcome to the Roundtable, a forum for incisive commentary and analysis
on cases and developments in law and the legal system.


INTERESTED IN wRITING FOR tHE rOUNDTABLE?

Moderna breaks 2020 pledge not to enforce its COVID-19-related patents

1/7/2023

0 Comments

 
Picture
By Sophie Gu

Sophie Gu is a second-year student in the School of Engineering and Applied Sciences at the University of Pennsylvania. She plans to double major in bioengineering and cognitive science with a concentration in computation and cognition.
​

Moderna’s recent mRNA patent infringement suit against Pfizer and BioNTech may signal a step towards the end of the two and a half year long COVID-19 Public Health Emergency. Despite Biden’s declaration that the “pandemic is over,” the Department of Health and Human Services has continued to renew PHE (Public Health Emergency) since its implementation in January 2020 [1] — it was last renewed this October. Since its first implementation in 2005 in response to Hurricane Katrina, section 319 of the Public Health Service Act has been used to address issues ranging from the Opioid Crisis to Monkeypox [2]. Although the United States is no stranger to PHEs, the COVID-19 Public Health Emergency has been one of the longest and most expensive PHEs to date [3].
In October of 2020, Moderna pledged to waive its COVID-related patents during the pandemic. On its website, Moderna stated that “while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic” [4]. This pledge was meant to ensure access to mRNA technology and facilitate COVID-19 vaccine development across the world.​

Moderna has now revoked its pledge, claiming that Pfizer and BioNTech’s COVID-19 vaccine infringes mRNA patents Moderna filed between 2010 and 2016. Pfizer has denied allegations of copying a full-length spike protein in a lipid nanoparticle formulation, claiming its mRNA research began prior to Moderna’s disputed patents [5]. Moderna is now seeking damages and lost profits from its COVID-related patents in “wealthier” countries.

In an effort to continue supporting pandemic relief efforts in low and middle-income countries, Moderna will not enforce the patents in the 92 low to middle low income countries listed in the Gavi COVAX Advance Market Commitment (AMC) [6]. However, this exception is provided that the COVID-19 vaccines will only be for use within those countries. Moderna will additionally not pursue any damages against the U.S. government, which has bought hundreds of millions of doses of the Pfizer-BioNTech vaccine.

By altering its 2020 pledge, Moderna is effectively suggesting that the pandemic is over, says Rochelle C. Dreyfuss, a professor at the New York University School of Law [7]. However, the fact that the US has continued to funnel billions of dollars into COVID-19 vaccine development and remains in a state of Public Health Emergency may complicate the outcome of Moderna's patent infringement lawsuit. Furthermore, decades of compounding mRNA research may also complicate Moderna’s claims to its mRNA patents. Both Moderna and Pfizer additionally utilized mRNA research from other previously filed patents, including an mRNA patent from the University of Pennsylvania in 2005 [8].
​

Though Moderna has launched a likely expensive and prolonged legal battle, SVB Securities analysts predict that Moderna’s litigation is unlikely to stall access to COVID-19 vaccines or stunt the development of mRNA innovation [9]. Notably, Moderna does not seek to eliminate Pfizer vaccines from the market, but rather expects its mRNA rivals to "respect its intellectual property rights and would consider a commercially reasonable license” [10]. The outcome of the case could ultimately decide whether Pfizer, BioNTech, or Moderna control the lucrative medical technology that mRNA promises.

Sources

[1] Sullivan, Becky, and Rob Stein. “How Biden’s Declaring the Pandemic ‘over’ Complicates 
Efforts to Fight COVID.” NPR.org, 20 Sept. 2022, 
www.npr.org/sections/health-shots/2022/09/20/1123883468/biden-pandemic-over-compli
cates-fight.

[2]“Federal Emergency Authorities :” MACPAC, 18 Mar. 2021, 
www.macpac.gov/subtopic/federal-emergency-authorities.

[3]“Federal Emergency Authorities :” MACPAC, 18 Mar. 2021, 
www.macpac.gov/subtopic/federal-emergency-authorities. 
[4] Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna’s Innovative 
mRNA Technology Platform.
investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-f
or-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/defa
ult.aspx.

[5] Taylor, Chloe. “Pfizer-BioNTech ‘Surprised’ by Moderna Lawsuit Alleging They Copied 
COVID-19 Vaccine Technology.” Fortune, 26 Aug. 2022, 
fortune.com/2022/08/26/pfizer-biontech-surprised-by-moderna-lawsuit-alleging-they-cop
ied-their-covid-19-vaccine-technology.

[6] Gavi COVAX AMC. www.gavi.org/gavi-covax-amc. 
[7] Vitale, Gina. “Moderna Sues Pfizer and BioNTech over COVID-19 Vaccine.” Cen.acs.org, 
https://cen.acs.org/policy/intellectual-property/Moderna-sues-Pfizer-BioNTech-over/100/
web/2022/08#.

[8] “The Tangled History of mRNA Vaccines.” Nature, 22 Oct. 2021, 
www.nature.com/articles/d41586-021-02483-w?error=cookies_not_supported&code=a14
c70c3-91a3-4d37-9ed2-fce90f3adf06.

[9] “Pfizer-BioNTech ‘Surprised’ by Moderna Lawsuit Alleging They Copied COVID-19 
Vaccine Technology.” Fortune, 26 Aug. 2022, 
fortune.com/2022/08/26/pfizer-biontech-surprised-by-moderna-lawsuit-alleging-they-cop
ied-their-covid-19-vaccine-technology.

[10] “Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative 
Mrna Technology Platform.” Moderna Sues Pfizer and BioNTech for Infringing Patents 
Central to Moderna's Innovative MRNA Technology Platform, 
https://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioN
Tech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platfor
m/. 
​

The opinions and views expressed in this publication are the opinions of the designated authors and do not reflect the opinions or views of the Penn Undergraduate Law Journal, our staff, or our clients.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.


    Categories

    All
    Akshita Tiwary
    Alana Bess
    Alana Mattei
    Albert Manfredi
    Alexander Saeedy
    Alexandra Aaron
    Alexandra Kanan
    Alice Giannini
    Alicia Augustin
    Alicia Kysar
    Ally Kalishman
    Ally Margolis
    Alya Abbassian
    Anika Prakash
    Anna Schwartz
    Ashley Kim
    Astha Pandey
    Audrey Pan
    Benjamin Ng'aru
    Brónach Rafferty
    Bryce Klehm
    Cary Holley
    Christina Gunzenhauser
    Christine Mitchell
    Christopher Brown
    Clarissa Alvarez
    Cole Borlee
    Connor Gallagher
    Dan Spinelli
    Dan Zhang
    David Katz
    Davis Berlind
    Derek Willie
    Dhilan Lavu
    Edgar Palomino
    Edna Simbi
    Emma Davies
    Esther Lee
    Evelyn Bond
    Filzah Belal
    Frank Geng
    Gabriel Maliha
    Georgia Ray
    Graham Reynolds
    Habib Olapade
    Hailie Goldsmith
    Haley Son
    Harshit Rai
    Henry Lininger
    Hetal Doshi
    Iris Zhang
    Irtaza Ali
    Isabela Baghdady
    Ishita Chakrabarty
    Jack Burgess
    Jessica "Lulu" Lipman
    Joe Anderson
    Jonathan Lahdo
    Jonathan Stahl
    Joseph Squillaro
    Justin Yang
    Kaitlyn Rentala
    Kanishka Bhukya
    Katie Kaufman
    Kelly Liang
    Keshav Sharma
    Ketaki Gujar
    Lauren Pak
    Lavi Ben Dor
    Libby Rozbruch
    Lindsey Li
    Luis Bravo
    Lyndsey Reeve
    Madeline Decker
    Maja Cvjetanovic
    Maliha Farrooz
    Marco DiLeonardo
    Margaret Lu
    Matthew Caulfield
    Michael Keshmiri
    Mina Nur Basmaci
    Muskan Mumtaz
    Natalie Peelish
    Natasha Darlington
    Natasha Kang
    Nayeon Kim
    Nicholas Parsons
    Nicholas Williams
    Nicole Greenstein
    Nihal Sahu
    Omar Khoury
    Owen Voutsinas Klose
    Owen Voutsinas-Klose
    Pheby Liu
    Rachel Bina
    Rachel Gu
    Rachel Pomerantz
    Rebecca Heilweil
    Regina Salmons
    Sajan Srivastava
    Sandeep Suresh
    Sanjay Dureseti
    Sarah Simon
    Saranya Das Sharma
    Saranya Sharma
    Sasha Bryski
    Saxon Bryant
    Sean Foley
    Sebastian Bates
    Serena Camici
    Shahana Banerjee
    Shannon Alvino
    Shiven Sharma
    Siddarth Sethi
    Sneha Parthasarathy
    Sneha Sharma
    Sophie Lovering
    Steven Jacobson
    Suaida Firoze
    Suprateek Neogi
    Takane Shoji
    Tanner Bowen
    Taryn MacKinney
    Thomas Cribbins
    Todd Costa
    Tyler Larkworthy
    Vatsal Patel
    Vikram Balasubramanian
    Vishwajeet Deshmukh
    Wajeeha Ahmad
    Yeonhwa Lee

    Archives

    January 2023
    December 2022
    November 2022
    September 2022
    June 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    December 2017
    November 2017
    October 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    April 2016
    March 2016
    February 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    November 2014
    October 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    December 2013
    November 2013
    October 2013
    September 2013

Picture
Picture
​